Compositions for treating or preventing obesity and insulin resistance disorders

Details for Australian Patent Application No. 2006266125 (hide)

Owner The General Hospital Corporation President and Fellows of Harvard College

Inventors Sinclair, David A.; Alexander-Bridge, Maria

Agent Shelston IP

Pub. Number AU-A-2006266125

PCT Pub. Number WO2007/005453

Priority 11/174,000 01.07.05 US

Filing date 28 June 2006

Wipo publication date 11 January 2007

International Classifications

A61K 31/00 (2006.01)

A61K 31/05 (2006.01)

A61K 31/12 (2006.01) - Ketones

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/005453 Priority application(s): WO2007/005453

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006266129-Amlno5-(5-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation

2006266124-High performance resin for abrasive products